Topic Paragraphs
Call-To-Action Title
Joint Media Call: FDA & CDC to Discuss Janssen COVID-19 Vaccine
Call-To-Action Title
Joint Media Call: FDA & CDC to Discuss Janssen COVID-19 Vaccine
A joint media briefing with the U.S. Centers for Disease Control and Prevention and the U.S. Food and Drug Administration to discuss six reported cases of a rare type of blood clot in individuals who received the Janssen COVID-19 Vaccine.
Listen to the Media Call
FDA Covid-19 Response
FDA is working with U.S. Government partners, including CDC, and international partners to address the pandemic.
Featured Topics
New Era of Smarter Food Safety
A new approach to food safety that recognizes and builds on the progress made in the past but looks towards what processes and tools will be needed for the future.
Fostering Drug Competition
Increasing the availability of generic drugs helps to create competition in the marketplace, helping make treatment more affordable and increasing access to healthcare for more patients.
Combating the Opioid Crisis
FDA takes actions to combat prescription opioid abuse.
Recalls, Market Withdrawals, & Safety Alerts
The FDA provides information gathered from press releases and other public notices about certain recalls of FDA-regulated products. Not all recalls have press releases or are posted on this website
Apr 13
Snak King Corporation Issues Allergy Alert on Undeclared Milk Allergen in Trader Joe’s Restaurant Style White Corn Tortilla Chips - Expanded to Include 8/11/21 Code Date
Food & Beverages
Apr 13
Urgent: Torn & Glasser Recalls Dark Chocolate Espresso Beans Because of Undeclared Walnut Allergen
Food & Beverages
Apr 10
Voluntary Recall of Hostess® SnoBalls® Due to Undeclared Allergen
Food & Beverages
Paragraph Header
FDA VOICES: PERSPECTIVES FROM FDA EXPERTS
Vaccine Ready: Addressing COVID-19 Health Disparities among Racial and Ethnic Minority Communities
As FDA celebrates National Minority Health Month we’re working to address concerns about vaccines among diverse communities.
Accelerating Medical Device Innovation with Regulatory Science Tools
Regulatory science tools can play a key role in accelerating patient access to innovative, safe, and effective medical devices.
FDA’s Ongoing Use of Inspectional Tools for Ensuring Access to Safe, Quality Food and Medical Products During the COVID-19 Pandemic
Over the past year, FDA’s approach to foreign and domestic inspections for food and medical products has been both risk-based and deliberate.
Recently Published Guidances
Apr 14
Remote Interactive Evaluations of Drug Manufacturing and Bioresearch Monitoring Facilities During the COVID-19 Public Health Emergency Guidance for Industry
Animal & Veterinary, Biologics, Drugs
Apr 05
Development of Abbreviated New Drug Applications During the COVID-19 Pandemic – Questions and Answers Guidance for Industry
Drugs
Mar 30
Guidance for Industry: Enforcement Policy for Providing an Acceptable Unique Facility Identifier (UFI) for the 2020 Food Facility Registration Biennial Renewal Period
Food & Beverages